BACKGROUND: In acute decompensated heart failure (ADHF) the risk of acute kidney injury (AKI) is high. Early detection of patients at risk for AKI is important. We tested urinary [TIMP-2] × [IGFBP7], a new US Food and Drug Administration-cleared test to assess AKI risk, in a cohort of hospitalized ADHF patients. HYPOTHESIS: In patients with ADHF, urinary [TIMP-2] × [IGFBP7] is associated with moderate to severe AKI and related to increased mortality. METHODS: We enrolled 400 patients in the emergency department at Robert-Bosch Hospital, Stuttgart, Germany. We examined the predictive ability of urinary [TIMP-2] × [IGFBP7] (units: [ng/mL]2 /1000) for development of AKI stage 2 or 3 within 24 hours of sample collection in patients with ADHF. Operating characteristics were determined for the validated cutoffs of 0.3 and 2.0. RESULTS: Forty patients had ADHF upon presentation and sufficient data for AKI staging. 27.5% developed AKI stage 2-3 within 7 days. Urinary [TIMP-2] × [IGFBP7] discriminated for AKI stage 2-3 over the first day with an area under the ROC curve of 0.84 (95% confidence interval: 0.72-0.93) and over 7 days with an AUC of 0.77 (95% confidence interval: 0.65-0.88). For the first day, sensitivity was 86% at the 0.3 cutoff and specificity was 95% at the 2.0 cutoff for prediction of AKI stage 2-3. There was a trend (P = 0.08) for higher mortality in patients with urinary [TIMP-2] × [IGFBP7] >2.0 and AKI 2-3. CONCLUSIONS: Urinary [TIMP-2] × [IGFBP7] is a promising marker for AKI risk assessment in patients with ADHF.
BACKGROUND: In acute decompensated heart failure (ADHF) the risk of acute kidney injury (AKI) is high. Early detection of patients at risk for AKI is important. We tested urinary [TIMP-2] × [IGFBP7], a new US Food and Drug Administration-cleared test to assess AKI risk, in a cohort of hospitalized ADHF patients. HYPOTHESIS: In patients with ADHF, urinary [TIMP-2] × [IGFBP7] is associated with moderate to severe AKI and related to increased mortality. METHODS: We enrolled 400 patients in the emergency department at Robert-Bosch Hospital, Stuttgart, Germany. We examined the predictive ability of urinary [TIMP-2] × [IGFBP7] (units: [ng/mL]2 /1000) for development of AKI stage 2 or 3 within 24 hours of sample collection in patients with ADHF. Operating characteristics were determined for the validated cutoffs of 0.3 and 2.0. RESULTS: Forty patients had ADHF upon presentation and sufficient data for AKI staging. 27.5% developed AKI stage 2-3 within 7 days. Urinary [TIMP-2] × [IGFBP7] discriminated for AKI stage 2-3 over the first day with an area under the ROC curve of 0.84 (95% confidence interval: 0.72-0.93) and over 7 days with an AUC of 0.77 (95% confidence interval: 0.65-0.88). For the first day, sensitivity was 86% at the 0.3 cutoff and specificity was 95% at the 2.0 cutoff for prediction of AKI stage 2-3. There was a trend (P = 0.08) for higher mortality in patients with urinary [TIMP-2] × [IGFBP7] >2.0 and AKI 2-3. CONCLUSIONS: Urinary [TIMP-2] × [IGFBP7] is a promising marker for AKI risk assessment in patients with ADHF.
Authors: Margarida Alvelos; Patrícia Lourenço; Carla Dias; Marta Amorim; Joana Rema; Ana Bento Leite; João Tiago Guimarães; Pedro Almeida; Paulo Bettencourt Journal: Int J Cardiol Date: 2011-08-27 Impact factor: 4.164
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Charanjit S Rihal; Stephen C Textor; Diane E Grill; Peter B Berger; Henry H Ting; Patricia J Best; Mandeep Singh; Malcolm R Bell; Gregory W Barsness; Verghese Mathew; Kirk N Garratt; David R Holmes Journal: Circulation Date: 2002-05-14 Impact factor: 29.690
Authors: Marco Metra; Savina Nodari; Giovanni Parrinello; Tania Bordonali; Silvia Bugatti; Rossella Danesi; Benedetta Fontanella; Carlo Lombardi; Patrizia Milani; Giulia Verzura; Gadi Cotter; Howard Dittrich; Barry M Massie; Livio Dei Cas Journal: Eur J Heart Fail Date: 2008-02 Impact factor: 15.534
Authors: Kevin Damman; Gerjan Navis; Adriaan A Voors; Folkert W Asselbergs; Tom D J Smilde; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege Journal: J Card Fail Date: 2007-10 Impact factor: 5.712
Authors: Josée Bouchard; Sharon B Soroko; Glenn M Chertow; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta Journal: Kidney Int Date: 2009-05-13 Impact factor: 10.612
Authors: Alan S Maisel; Christian Mueller; Robert Fitzgerald; Robert Brikhan; Brian C Hiestand; Navaid Iqbal; Paul Clopton; Dirk J van Veldhuisen Journal: Eur J Heart Fail Date: 2011-08 Impact factor: 15.534
Authors: Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski Journal: Eur Heart J Date: 2009-12-25 Impact factor: 29.983
Authors: Federico Nalesso; Leda Cattarin; Laura Gobbi; Antonio Fragasso; Francesco Garzotto; Lorenzo Arcangelo Calò Journal: Int J Nephrol Renovasc Dis Date: 2020-04-24
Authors: Jan Waskowski; Carmen A Pfortmueller; Noelle Schenk; Roman Buehlmann; Juerg Schmidli; Gabor Erdoes; Joerg C Schefold Journal: PLoS One Date: 2021-01-07 Impact factor: 3.240
Authors: Hyun Suk Yang; Mina Hur; Kyeong Ryong Lee; Hanah Kim; Hahn Young Kim; Jong Won Kim; Mui Teng Chua; Win Sen Kuan; Horng Ruey Chua; Chagriya Kitiyakara; Phatthranit Phattharapornjaroen; Anchalee Chittamma; Thiyapha Werayachankul; Urmila Anandh; Sanjeeva Herath; Zoltan Endre; Andrea Rita Horvath; Paola Antonini; Salvatore Di Somma Journal: Ann Lab Med Date: 2022-03-01 Impact factor: 3.464
Authors: Anna Lisowska; Anna Szyszkowska; Małgorzata Knapp; Magda Łapińska; Marcin Kondraciuk; Inga Kamińska; Tomasz Hryszko; Katarzyna Ptaszyńska-Kopczyńska; Karol Kamiński Journal: Biomolecules Date: 2022-02-08
Authors: Wen Tao Liu; Xiao Qi Liu; Ting Ting Jiang; Meng Ying Wang; Yang Huang; Yu Lin Huang; Feng Yong Jin; Qing Zhao; Qin Yi Wu; Bi Cheng Liu; Xiong Zhong Ruan; Kun Ling Ma Journal: Front Cardiovasc Med Date: 2022-09-07
Authors: Evelyn M Templeton; Moritz Lassé; Torsten Kleffmann; Leigh J Ellmers; Suetonia C Palmer; Trent Davidson; Nicola J A Scott; John W Pickering; Christopher J Charles; Zoltan H Endre; Vicky A Cameron; A Mark Richards; Miriam T Rademaker; Anna P Pilbrow Journal: Int J Mol Sci Date: 2022-01-17 Impact factor: 5.923